Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: elmatador who wrote (65771)	7/1/2005 5:32:19 AM
From: shades	Read Replies (1) \| Respond to of 74559

I thought the recent DR CAFTA was gonna help rich drug companies keep these guys from not paying high drug prices? project-syndicate.org Consider pharmaceuticals. For American DRUG companies, this agreement extends the time period during which brand-name pharmaceuticals have exclusive access to markets, postponing the entry of generic DRUGs and thus limiting competition. For Central Americans, the cost of DRUGs will soar, straining budgets and gutting health care. The result may be a death sentence for many. Do they really think they are gonna keep getting away with this? hehe